MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Ind-Swift Laboratories
BSE: 532305|NSE: INDSWFTLAB|ISIN: INE915B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
41.60
0.3 (0.73%)
VOLUME 29,662
LIVE
NSE
May 24, 17:00
41.35
-0.2 (-0.48%)
VOLUME 35,923
Announcements on Ind-Swift Labs

25th-Apr-2013 15:29Source: NSE

Ind-Swift Laboratories Limited

Essix Biosciences Limited has submitted to the Exchange vide letter dated April 18, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeov...

25th-Apr-2013 15:29Source: NSE

Ind-Swift Laboratories Limited

Essix Biosciences Limited has submitted to the Exchange vide letter dated April 18, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeov...

11th-Apr-2013 13:16Source: BSE

Ind-Swift Labs - Updates

Ind-Swift Laboratories Ltd has informed BSE as about:

1. Shri R.K. Ummat has been appointed as an Independent Director on the Board of the Company.

2. That the secured debt of the Compa...

10th-Apr-2013 20:41Source: NSE

Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited has informed the Exchange that the secured debt of the Company have been restructured under Corporate Debt Restructuring mechanism by majority secured Creditors on Decem...

10th-Apr-2013 20:37Source: NSE

Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited has informed the Exchange that Shri R. K. Ummat has been appointed as an Independent Director on the Board of the Company.

13th-Mar-2013 21:00Source: NSE

Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited has informed the Exchange that Shri. Atul Saxena has ceased to be a Nominee Director on the Board of Directors of the Company pursuant to withdrawal of nomination by IFC...

13th-Mar-2013 16:17Source: BSE

Ind-Swift Labs - Cessation of Director

Ind-Swift Laboratories Ltd has informed BSE that Shri. Atul Saxena has ceased to be a Nominee Director on the Board of Directors of the Company pursuant to withdrawal of nomination by IFCI w.e.f. Febr...

8th-Mar-2013 18:10Source: NSE

Ind-Swift Laboratories Limited

Ind-Swift Limited has submitted to the Exchange vide letter dated March 08, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Reg...

8th-Mar-2013 17:06Source: BSE

Ind-Swift Labs - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Ind-Swift Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

19th-Feb-2013 18:31Source: BSE

Ind-Swift Labs - Information related to Employee Benefit Scheme

Ind-Swift Laboratories Ltd has submitted to BSE the details of Ind-Swift Labs Employee Stock Option Scheme.

1 2 3 4 5 Next >>
Board Meeting (Ind-Swift Labs)

Meeting Date

Remark

2013-05-28

Audited Results

Quick Links for Ind-Swift Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.